Global Microfluidics Market by Application (Lab-on-a-chip, Organs-on-chips), by Technology (Medical, Non-medical), by Material (Polymer, Silicon, Glass, PDMS) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global microfluidics market was valued at USD 17.9 Billion in 2020. It is projected to grow at a compound annual rate (CAGR of 16.3%) between 2021 and 2028. The growing number of clinical trials for cell-based therapies is driving the market. Market growth is being driven by the rapid demand for low-volume sample analyses, high-throughput screening methods, IVF (IVD), as well as advanced lab-on-a chip technologies. Microfluidics is a great investment because it minimizes errors and offers high returns on investment.

Routine blood glucose levels checks can be performed at home for pre-hospital analysis. This reduces hospital stays and minimizes the need to visit the hospital. Market players introduced point of care diagnostics which resulted in fewer hospital visits and earlier diagnosis. Industry players can now differentiate their products with minimally invasive technologies that are fast and accurate. Microfluidics is now a major player in the IVD market.

Miniaturization is also crucial to allow microfluidics technology to be applied to wearable devices. The concept of incorporating microfluidics to manufacture pocket-sized/wearable devices has encouraged various large companies such as F. Hoffmann-La Roche Ltd., BD (Becton Dickinson and Company), and Abbott to expand their microfluidics portfolio across clinical, Point-of-Care (POC), and veterinary diagnostics. Fluidigm Corp., Illumina, Inc., and Agilent Technologies, Inc. are other key vendors.

Microfluidics is gaining popularity in diagnostics, particularly in POC diagnostics. This is also supplemented by microfluidics-integrated biosensor technologies that are expected to enhance POC diagnostics. Combining microfluidic components and POC devices will largely focus on sensitivity, stability accuracy, affordability, as well as obtaining minimally invasive OOC technology.

In the current COVID-19 management, it is important to get a quick diagnosis. Point-of-care testing for COVID-19 patients has been possible due to the longer turnaround times required by commercialized COVID-19 test, and the time it takes hospitals and large-scale labs to return the results to the patient. Microfluidics can be used to develop COVID-19 point of care testing. It has a rapid turnaround time, a clinically relevant detection limit and allows for the creation of cost-effective tests.

Technology Insights

In 2020, the market was dominated by the medical technology segment which accounted for 83.3% of the total revenue. Microfluidics has been gaining momentum in Point-of-Care diagnostics (POC), because it offers several benefits that allow for the development of new POC diagnostics. These advantages are slowly being used to create POC diagnostics for a wide range of conditions including cancer and infectious diseases.

The key contributors to the revenue of the medical technology sector's revenues are PCR and RTPCR. In 2020, the former accounted for over 30%. PCR is one the most widely used and reliable techniques in molecular diagnosis. There are two types of DNA amplification: isothermal or non-isothermal. All of these techniques can be used in conjunction with microfluidics. PCR, on the other hand is the most widely used non-isothermal technology for DNA amplification in microfluidic devices.

From 2021 to 2028, the non-medical market is expected to grow at 14.4%. The non-medical market will see microfluidics used for the extraction of crude oil from porous rocks, detection and production of gas bubbles of various sizes. It is difficult to see fluid flow through porous media optically.

Crude oil flow through rocks is limited by factors like connectivity and tortuosity. The flow is also affected by the complex interactions between fluids and geometry. The microfluidic technology can be used to develop techniques for extracting crude oil trapped in porous rocks, mixed with pollutants.

Application Insights

Lab-on-achip dominated the market, accounting for 38.5% of the total revenue in 2020. The lab-on-a chip provides fast detection and maintains the required sensitivity for DNA or RNA amplifying and detection processes. This makes it ideal for molecular biology applications. Lab-on-chip allows for rapid sequencing of DNA probes. The lab-on-chip performs high-speed thermal shifts at microscale levels because DNA amplification using the PCR technique is dependent on temperature cycles.

However, lab-on a-chip research in cell biology has shown promise. These systems can regulate cells at the single cell level and deal with large numbers of cells in a very short time span. Elveflow's Opto Reader is a fast-optical detector that allows for high-throughput cell isolation and detection. These systems can also be used for stem cell differentiation, micro-clamp, cell sorting and high-speed flow Cytometry.

The organs-onchips segment will see a 21.9% CAGR over the forecast period. An organ-on-chip microchip that is embedded with living cells can mimic many body processes, including peristalsis and infection. These models are crucial in drug discovery and drug development.

Through its Tissue Chip for Drug Screening initiative, the National Center for Advancing Translational Science and the FDA, the NCATS focuses on drug discovery by creating human tissue chips that accurately represent human organs.

Material Insights

The Microfluidics market was dominated by the Polydimethylsiloxane segment (PDMS), which accounted for 34.7% of the total revenue in 2020. Other polymers have been gaining popularity for polydimethylsiloxane, especially in microfluidic devices that allow rapid prototyping. These polymers are well-liked by academic professionals due to their ease of fabrication and affordability.

To address the hydrophobicity of PDMS, a variety of PDMS surface modifications have been introduced to the market. Hydrophobicity makes it difficult to operate microchannels in aqueous solutions. This is due to the fact that analytes can get stuck on the PDMS surface and interfere with the analysis.

Glass was the 2 ^nd in terms of revenue in 2020. It is expected to grow at a CAGR 14.4%. The majority of microfluidics devices made from glass are used for analysis with organic solvents and elevated temperatures. Glass is an amorphous, transparent material that is both electrically and optically insulated.

For processing glass-based microfluidics devices, standard photolithography as well as wet and dryetching are used. Special etching techniques can be used to create microfluidic devices with etched glass channels that have rounded sidewalls.

Regional Insights

North America was the dominant market, accounting for 43.2% of the total revenue in 2020. Research institutes are actively involved in the development of new microfluidic devices. This will ensure that the region continues to be a dominant player on the global market. The U.S. was a major contributor to the region’s dominance during the study period. The country is home to many emerging companies involved in the manufacturing of microfluidics products, as well as established players.

Microfluidics, an American company, offers a proprietary microfluidics technology called Microfluidizer. This technology is used to manufacture high shear fluid processors that can achieve efficient cell disruption, nanoemulsions and reduction in particle size. The market for Asia Pacific is expected to grow at 17.1% during the forecast period.

China's market for high-throughput screening and medical diagnostics is expanding. This is due to strong intellectual property rights ownership and government support for advanced infrastructure. Another driving factor was the growing demand for healthcare services. China is a developing nation with huge potential.

Market Share Insights & Key Companies

To strengthen their market position, companies are launching facility expansions and collaborations. Illumina, for example, announced in June 2020 its latest group of startups that would be working with its teams in London and San Francisco. The cohort also includes WellSIM Biomedical Technologies, Inc., a microfluidics startup entity. This company produces high-throughput automated processing units based on microfluidics that are used for the isolation and analysis exosomes. The microfluidics industry is dominated by the following players:

• Illumina, Inc.

• F. Hoffmann-La Roche Ltd

• PerkinElmer, Inc.

• Agilent Technologies, Inc.

• Bio-Rad Laboratories Inc.

• Danaher Corporation

• Life Technologies Corporation

• Abbott Laboratories

• Thermo Fisher Scientific

• Qiagen

• Biomerieux

• Elveflow

• Cellix Ltd.

• Micronit Micro Technologies B.V.

• Fluidigm Corporation

Up Market Research published a new report titled “Microfluidics Market research report which is segmented by Application (Lab-on-a-chip, Organs-on-chips), by Technology (Medical, Non-medical), by Material (Polymer, Silicon, Glass, PDMS), By Players/Companies Thermo Fisher Scientific, Elveflow, F Hoffmann-La Roche Ltd, Fluidigm Corporation, Cellix Ltd, Bio-Rad Laboratories Inc, Qiagen, Biom©rieux, PerkinElmer Inc, Abbott Laboratories, Danaher Corporation, Life Technologies Corporation, Illumina Inc, Micronit Micro Technologies BV, Agilent Technologies Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Microfluidics Market Report Segments:

The market is segmented by Application (Lab-on-a-chip, Organs-on-chips), by Technology (Medical, Non-medical), by Material (Polymer, Silicon, Glass, PDMS).

Microfluidics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Microfluidics Market

Overview of the regional outlook of the Microfluidics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Microfluidics Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Microfluidics Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Lab-on-a-chip

                2. Organs-on-chips

                1. Medical

                2. Non-medical

                1. Polymer

                2. Silicon

                3. Glass

                4. PDMS

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Microfluidics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Microfluidics Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.